TREAT Asia News
-
Integrating Hepatitis B and HIV PrEP Services Makes Sense
amfAR’s TREAT Asia program highlights an opportunity to improve the lives of vulnerable populations.
-
The Asia-Pacific Region Has the World’s Highest Burden of Hepatitis B
In a new issue brief, amfAR’s TREAT Asia outlines the urgent health needs of people at risk for or impacted by chronic hepatitis B virus infection.
-
TREAT Asia Researchers Present at Asia-Pacific HIV Conference
amfAR staff and network investigators shared findings on HIV and mental health, among other topics, at APACC 2023.
-
TREAT Asia Launches Community-led Monitoring Dashboard
amfAR and its partners aim to help improve HIV and hepatitis service delivery in India and Indonesia.
-
Better Data, Better Health
Smita Nimkar, a researcher in amfAR’s TREAT Asia network, explains how improving her data skills as a Fogarty-IeDEA trainee is enriching her research on children living with HIV.
-
TB and HIV: A Deadly Duo
A new study aims to improve health outcomes for people who are co-treated for tuberculosis disease and HIV.
-
Cannabis, Youth, and Public Health: Assessing the Pitfalls of Legalization
Decriminalization of cannabis in Thailand deserves public health policy guidance to protect youth.
-
HIV and Youth in Thailand: Addressing Suicide Risk
A new study seeks to create mental health interventions for a vulnerable population.
-
Improving Transgender Health in Southeast Asia
A new study seeks to improve HIV-related transgender health in Thailand, Vietnam, and the Philippines.
-
HIV Care Continuum & Beyond: A New Era for Asia
With TREAT Asia as one of its partners, an initiative strives to strengthen HIV policies and programs across a regional cascade of care.
-
Dangerous Inequalities
New UNAIDS report identifies key drivers of the HIV epidemic: gender inequalities, discrimination against key populations, and failures to address needs of children with HIV.
-
TREAT Asia Calls for Expanded Access to Pediatric Dolutegravir
Facilitating access to formulations of the HIV medicine dolutegravir (DTG) that can be used by infants and children living with HIV in the Asia-Pacific is an urgent concern. In light of recent U.S. and European regulatory approvals of a dispersible version of pediatric DTG, amfAR’s TREAT Asia program recommends steps that national HIV programs and…
-
Recent ARV Stockouts in India Created a Health Crisis for People Living with HIV
An antiretroviral therapy stockout in India limited treatment options and created barriers to healthcare access for people living with HIV.
-
UNAIDS: Most New HIV Infections Among Children Are Preventable
UNAIDS estimates that most of the 150,000 new HIV infections among children in 2020 could have been prevented.
-
COVID-19 Pandemic Threatens HIV Drug Supplies
There is mounting concern in many countries, and emerging acutely in Asia, about a growing shortage of lifesaving antiretroviral drugs as a result of supply chain disruptions and stock-outs caused by the COVID-19 pandemic. Experts fear that further disruptions could halt and even reverse the hard-won progress on HIV/AIDS that has been achieved in many…